Cardiovascular adverse events in modern myeloma therapy – Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)

Cardiovascular disease in patients with multiple myeloma may derive from factors unrelated to the disease (age, diabetes, dyslipidemia, obesity, prior cardiovascular diseases), related to the disease (cardiac AL-amyloidosis, hyperviscosity, high-output failure, arteriovenous shunting, anemia, renal...

Descripción completa

Detalles Bibliográficos
Autores principales: Bringhen, Sara, Milan, Alberto, Ferri, Claudio, Wäsch, Ralph, Gay, Francesca, Larocca, Alessandra, Salvini, Marco, Terpos, Evangelos, Goldschmidt, Hartmut, Cavo, Michele, Petrucci, Maria Teresa, Ludwig, Heinz, Auner, Holger W., Caers, Jo, Gramatzki, Martin, Boccadoro, Mario, Einsele, Hermann, Sonneveld, Pieter, Engelhardt, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119131/
https://www.ncbi.nlm.nih.gov/pubmed/30049825
http://dx.doi.org/10.3324/haematol.2018.191288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119131/
https://www.ncbi.nlm.nih.gov/pubmed/30049825
http://dx.doi.org/10.3324/haematol.2018.191288

Ejemplares similares